LABU Holdings Information

LABU is an equity ETF with a total of 171 individual holdings.

Total Holdings

171

Top 10 Percentage

35.21%

Asset Class

Equity

ETF Category

Trading--Leveraged Equity

Assets

452.33M

PE Ratio

n/a

Breakdown by Sector

No.	Symbol	Name	% Weight	Shares
1	n/a	Dreyfus Govt Cash Man Ins	12.46%	59,204,810
2	n/a	Goldman Finl Sq Trsry Inst 506	6.84%	32,496,547
3	n/a	S&P Biotechnology Select Industry Index Swap	4.29%	25,717
4	n/a	S&P Biotechnology Select Industry Index Swap	2.56%	20,646
5	n/a	S&P Biotechnology Select Industry Index Swap	2.42%	19,041
6	n/a	S&P Biotechnology Select Industry Index Swap	2.06%	15,532
7	APLS	Apellis Pharmaceuticals, Inc.	1.38%	161,268
8	n/a	S&P Biotechnology Select Industry Index Swap	1.12%	8,962
9	ALKS	Alkermes plc	1.06%	145,139
10	TGTX	TG Therapeutics, Inc.	1.03%	143,691
11	MDGL	Madrigal Pharmaceuticals, Inc.	1.02%	9,339
12	SRRK	Scholar Rock Holding Corporation	0.98%	93,340
13	INSM	Insmed Incorporated	0.97%	28,915
14	n/a	S&P Biotechnology Select Industry Index Swap	0.97%	6,011
15	APGE	Apogee Therapeutics, Inc.	0.94%	53,969
16	ARWR	Arrowhead Pharmaceuticals, Inc.	0.94%	69,371
17	TWST	Twist Bioscience Corporation	0.93%	86,012
18	PTCT	PTC Therapeutics, Inc.	0.92%	61,374
19	SMMT	Summit Therapeutics Inc.	0.92%	231,505
20	PRAX	Praxis Precision Medicines, Inc.	0.91%	13,570
21	NTRA	Natera, Inc.	0.91%	20,500
22	TVTX	Travere Therapeutics, Inc.	0.91%	136,211
23	KYMR	Kymera Therapeutics, Inc.	0.91%	49,443
24	UTHR	United Therapeutics Corporation	0.91%	7,400
25	MIRM	Mirum Pharmaceuticals, Inc.	0.91%	43,930

Showing 25 of 171 holdings

Subscribe to see the full list

As of Apr 8, 2026